John T. Gray

7.6k citations

55 papers · 2.8k indexed · h-index 28

Impact in

Genetics top 1%
- Virus-based gene therapy research
Molecular Biology top 5%
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Viral Infectious Diseases and Gene Expression in Insects
- Advanced biosensing and bioanalysis techniques
- RNA and protein synthesis mechanisms

Papers in ⓘ

Molecular Biology 39
- CRISPR and Genetic Engineering 17
- RNA Interference and Gene Delivery 15
- Viral Infectious Diseases and Gene Expression in Insects 12
- Advanced biosensing and bioanalysis techniques 2
Genetics 39
- Virus-based gene therapy research 39

Co-authors: Andrew M. Davidoff (19 shared papers)Amit C. Nathwani (14 shared papers)Catherine Y. Ng (8 shared papers)Junfang Zhou (6 shared papers)Yunyu Spence (5 shared papers)Jenny McIntosh (6 shared papers)Derek A. Persons (7 shared papers)Arthur W. Nienhuis (10 shared papers)
Journals: Blood (15 papers)Molecular Therapy (11 papers)Human Gene Therapy (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

John T. Gray

54 papers receiving 2.8k citations

Peers

Countries citing papers authored by John T. Gray

Since Specialization

Citations

This map shows the geographic impact of John T. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Gray more than expected).

Fields of papers citing papers by John T. Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Gray. The network helps show where John T. Gray may publish in the future.

Co-authors

The 25 scholars most cited alongside John T. Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John T. Gray Line = papers co-authored together John T. Gray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver Blood ·Amit C. Nathwani, John T. Gray, Catherine Y. Ng, Junfang Zhou, Yunyu Spence, Simon N. Waddington, Edward G. D. Tuddenham, Geoffrey Kemball‐Cook, Jenny McIntosh, Mariëtte Boon‐Spijker, Koen Mertens, Andrew M. Davidoff	2005	327
2	Exogenous control of mammalian gene expression through modulation of RNA self-cleavage Nature ·Laising Yen, Jennifer M. Svendsen, Jeng-Shin Lee, John T. Gray, Maxime Magnier, Takashi Baba, Robert J. D’Amato, Richard C. Mulligan	2004	210
3	Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates Blood ·Amit C. Nathwani, John T. Gray, Jenny McIntosh, Catherine Y. Ng, Junfang Zhou, Yunyu Spence, Melanie Cochrane, Elaine Gray, Edward G. D. Tuddenham, Andrew M. Davidoff	2006	210
4	Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models Molecular Therapy ·Andrew M. Davidoff, John T. Gray, Catherine Y. Ng, Youbin Zhang, Junfang Zhou, Yunyu Spence, Yusura Bakar, Amit C. Nathwani	2005	179
5	Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus–based lentiviral vector system Blood ·Hideki Hanawa, Peiman Hematti, Keyvan Keyvanfar, Mark E. Metzger, Allen E. Krouse, Robert E. Donahue, Steve Kepes, John T. Gray, Cynthia E. Dunbar, Derek A. Persons, Arthur W. Nienhuis	2004	133
6	Cloning and expression of genes for the Oxytricha telomere-binding protein: Specific subunit interactions in the telomeric complex Cell ·John T. Gray, Daniel W. Celander, Carolyn M. Price, Thomas R. Cech	1991	131
7	Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial Human Gene Therapy ·James A. Allay, Susan Sleep, Scott Long, David M. Tillman, Rob Clark, Gael Carney, Paolo Fagone, Jenny H. McIntosh, Arthur W. Nienhuis, Andrew M. Davidoff, Amit C. Nathwani, John T. Gray	2011	115
8	Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation Molecular Therapy ·Gustavo Mostoslavsky, Darrell N. Kotton, Attila J. Fabian, John T. Gray, Jeng-Shin Lee, Richard C. Mulligan	2005	110
9	Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection Blood ·Robert E. Throm, Annastasia Ouma, Sheng Zhou, Anantharaman Chandrasekaran, Timothy Lockey, Michael R. Greene, Suk See De Ravin, Morvarid Moayeri, Harry L. Malech, Brian P. Sorrentino, John T. Gray	2009	110
10	Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock Journal of Virological Methods ·Andrew M. Davidoff, Catherine Y. Ng, Susan Sleep, John T. Gray, Selina A. Azam, Yuan Zhao, Jenny H. McIntosh, Morteza Karimipoor, Amit C. Nathwani	2004	109
11	Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells Molecular Therapy ·Phillip W. Hargrove, Steven Kepes, Hideki Hanawa, John C. Obenauer, Deiqing Pei, Cheng Cheng, John T. Gray, Geoffrey Neale, Derek A. Persons	2008	90
12	A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells Blood ·Sheng Zhou, Disha A. Mody, Suk See De Ravin, Julia Hauer, Taihe Lu, Zhijun Ma, Salima Hacein-Bey Abina, John T. Gray, Michael R. Greene, Marina Cavazzana, Harry L. Malech, Brian P. Sorrentino	2010	87
13	Soluble receptor-mediated selective inhibition of VEGFR and PDGFRβ signaling during physiologic and tumor angiogenesis Proceedings of the National Academy of Sciences ·Frank Kuhnert, Betty Y. Tam, Barbara Sennino, John T. Gray, Jenny Yuan, Angeline Jocson, Nihar R. Nayak, Richard C. Mulligan, Donald M. McDonald, Calvin J. Kuo	2008	84
14	Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin Molecular Therapy ·Tamara I. Pestina, Phillip W. Hargrove, Dennis W. Jay, John T. Gray, Kelli M Boyd, Derek A. Persons	2008	83
15	Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods Human Gene Therapy Methods ·Paolo Fagone, J. Fraser Wright, Amit C. Nathwani, Arthur W. Nienhuis, Andrew M. Davidoff, John T. Gray	2012	73
16	Oxytricha telomere-binding protein: separable DNA-binding and dimerization domains of the alpha-subunit. Genes & Development ·G. Fang, John T. Gray, Thomas R. Cech	1993	62
17	An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation Blood ·Byoung Y. Ryu, Marguerite V. Evans‐Galea, John T. Gray, David M. Bodine, Derek A. Persons, Arthur W. Nienhuis	2007	62
18	Enhancing transduction of the liver by adeno-associated viral vectors Gene Therapy ·AC Nathwani, Melanie Cochrane, Jenny McIntosh, Catherine Y. Ng, Jianli Zhou, John T. Gray, Andrew M. Davidoff	2008	61
19	Antitumor efficacy of AAV-mediated systemic delivery of interferon-β Cancer Gene Therapy ·Christian J. Streck, Paxton V. Dickson, Catherine Y. Ng, Jianli Zhou, Mark Hall, John T. Gray, A C Nathwani, Andrew M. Davidoff	2005	46
20	Design and Construction of Functional AAV Vectors Methods in molecular biology ·John T. Gray, Serge Zolotukhin	2011	45

About John T. Gray

John T. Gray is a scholar working on Molecular Biology, Genetics, Oncology, Infectious Diseases and Hematology, having authored 55 papers that have together received 2.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (39 papers), CRISPR and Genetic Engineering (17 papers), CAR-T cell therapy research (15 papers), RNA Interference and Gene Delivery (15 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers), Viral gastroenteritis research and epidemiology (5 papers), Hemophilia Treatment and Research (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Genetics (1.7k citations), Molecular Biology (2.1k citations), Oncology (682 citations), Genetics (182 citations) and Infectious Diseases (277 citations). John T. Gray has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Andrew M. Davidoff, Amit C. Nathwani, Catherine Y. Ng, Junfang Zhou, Yunyu Spence, Jenny McIntosh, Derek A. Persons, Arthur W. Nienhuis, Thomas R. Cech and Richard C. Mulligan. Their work appears in journals such as Blood, Molecular Therapy, Human Gene Therapy, Journal of Antimicrobial Chemotherapy and Molecular Therapy — Methods & Clinical Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact